Intellipharmaceutics International Inc. (IPCI)

[Tekterra]

It's hard to determine value at this point Mopar. The three drugs should be green light all the way no problem. But 2.5 billion market is a combined sales data. I think IPCI expected something like a 10-20% market penetration meaning they expect to reach a about 500 million when all three are out in the market. This this needs to deduct cost involved in production and marketing. Leaving profit to split between IPCI and partner. Depending on the margin of selling the drugs. So this is still unclear until actual sales happen. Right now it's just a rough estimate of 500 million potential revenue. So we're not likely to see the stock value reflect this right now. But, hopefully, but mid 2017 sales can begin for all three drugs assuming we get approval soon on the other two.